BRAIN Biotech AG specializes in industrial biotechnology, focusing on providing sustainable products and processes through optimized enzymes, high-performance microorganisms, and bioactive compounds.

BRAIN Biotech AG

Lingo word game

日本 旅遊會話一指搞定(Point and Learn Japan Travel Conversation)

Fingerprint fortune telling

日本旅遊活動電子導覽書（VISIT JAPAN CAMPAIGN DIGITAL GUIDEBOOK）

Chess 3D Pro

Chess 3D Free

パスタ

rakutabi English

rakutabi German

さわって通訳

nginx

DMARC

Microsoft Exchange Online

Office 365 Mail

Microsoft Azure DNS

GoDaddy DNS

Common Name Invalid

Japanese Yen

GoDaddy

Chief Executive Officer

Aryan Moelker

Michael Schneiders

Adriaan Moelker

Chemical Public Companies With More Than 100 Employees

Germany Companies With More Than 100 Employees (Top 10K)

Germany Companies With Fewer Than 1000 Employees (Top 10K)

Europe, Middle East, and Africa (EMEA) Public Companies With Less Than $500M in Revenue

As industrial biotechnology specialists, BRAIN Biotech develops and produces enzymes, proteins, microbial production strains and bioactive natural products for industrial applications. In addition, the company´s innovative bio-based solutions help make industrial processes more sustainable. The company focuses on nutrition, health, and the environment. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group and has been listed on the Prime Standard of the Frankfurt Stock Exchange since 9 February 2016 (ticker symbol: BNN).

MP Beteiligungs

Post-IPO Debt - BRAIN Biotech AG

Private Equity Round - BRAIN Biotech AG

Computer and Software Services and Scientific Services

Zwingenberg

Hessen

Germany

Europe

BRAIN Biotech AG concludes royalty monetization deal for...

BRAIN Biotech AG. (8/22/24). "Press Release: BRAIN Biotech AG Launches the Innovative Technology Platform MetXtra Enabling Unique Enzyme Solutions". Zwingenberg.

BRAIN Biotech AG presents strong cash position with its 9...

BRAIN Biotech–de Vries E: management, 202406– Senior BusDev Director Enzymes before Enzymicals + Consultant + Dottikon + Amyris + Purolitee + Codexis

BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets

BRAIN Biotech AG takes next step to optimize group structure

Dr. Alexander Pelzer | Vice President, Head of Research & Development | BRAIN Biotech AG

Brain Biotech, AMSilk patent protein for performance apparel

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

HTML5

jQuery

Matomo (Formerly Piwik)

GoDaddy Premium DNS

GlobalSign

Vimeo

Apache Server

Modernizr

Fonts.com

BRAIN Biotech AG researches, develops, produces, and markets enzymes, biocatalysts, microorganisms, and bioactive natural substances for chemical industries in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates in two segments, BioScience and BioIndustrial. It identifies and develops bioactive natural compounds, including sugar substitutes and taste modulators, and nature-based active ingredients for product development in the food, animal feed, skin care, cosmetics, and chemical industries. The company also identifies and develops optimized enzymes and biocatalysts for the production of food and beverages, and wound care preparations or lubricants, as well as for starch processing of bioethanol production; and microorganisms as the functional biomass for optimized industrial production processes, recycling of greenhouse gas CO2 as an industrial raw material, and extraction of precious and rare earth metals. It has strategic partnerships with AnalytiCon Discovery GmbH and Roquette to develop natural sweeteners and sweet taste enhancers. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 2, 2024 9:42 PM	cb454670
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 2, 2024 9:42 PM	eb048dff
crunchbase trigger	general	Nov 2, 2024 9:42 PM	d8aadfa6
crunchbase profile	general	Nov 3, 2024 4:21 PM	09f62cf3
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	0276981b
peers	general	Nov 2, 2024 9:42 PM	dbd3a6c2
news basic	general	Nov 2, 2024 9:42 PM	6b1b8a57
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BNN

COM:BRAIN-BIOTECH

BRAIN Biotech AG

Last Close

3.15

25/11 09:24

Market Cap

50.25M

Beta: -

Volume Today

6.57K

Avg: -